Influence of chitosan thioglycolic acid conjugate in improving bioavailability of an antiparkinson drug; Rasagiline Mesylate from transdermal patch

References

• Michele PMG, Francesco MSZM. Rasagiline and rapid symptomatic motor effect in Parkinson’s. disease: review of literature. Neurol Ther. 2014;3:41–66.
   PubMedGoogle Scholar
• Paul L. McCormack. Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease. CNS Drugs. 2014;28(11):1083–1097.
   PubMed Web of Science ®Google Scholar
• Wenjia Z, Chengzhe L, Quanying Z, et al. Pharmacokinetics pharmacodynamics and safety of rasagiline transdermal patch: a preliminary study in healthy Chinese subjects. Clin Drug Investig. 2018;38(2):125–133.
   PubMed Web of Science ®Google Scholar
• Anna MW, Suneela P, William HD, et al. Transdermal drug delivery system TDDS adhesion as a critical safety, efficacy and quality attribute. Eur J Pharm Biopharm. 2006;64:1–8.
   PubMed Web of Science ®Google Scholar
• Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! J Control Release. 2014;190:150–156.
   PubMed Web of Science ®Google Scholar
• Pae C-U, Lim H-K, Han C, et al. Selegiline transdermal system: Current awareness and promise. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(6):1153–1163.
   PubMed Web of Science ®Google Scholar
• Reddy PS, Sudhakar BK, Navneet K. Development and validation of a stability-indicating RPHPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation. J Chromatogr Sci. 2013;51(3):242–249.
   PubMed Web of Science ®Google Scholar
• Xubing Y, Junping Z, Siming J, et al. A review on the preparation of chitosan oligosaccharides and application to human health, animal husbandry and agricultural production. Carbohydr Polym. 2019;220:60–70.
   PubMed Web of Science ®Google Scholar
• Pradeep KP, JenMing Y, YenHsiang C, et al. Modification of different molecular weights of chitosan by p-Coumaric acid: Preparation, characterization and effect of molecular weight on its water solubility and antioxidant property. Int J Biol Macromol. 2019;136:661–667.
   PubMed Web of Science ®Google Scholar
• Mittal H, Sinha Ray S, Singh Kaith B, et al. Recent progress in the structural modification of chitosan for applications in diversified biomedical fields. Eur Poly Journal. 2018;109:402–434.
   Web of Science ®Google Scholar
• Negm NA, Hefni HHH, Abd-Elaal AAA, et al. Advancement on modification of chitosan biopolymer and its potential applications. Int J Biol Macromol. 2020;152:681– 702.
   PubMed Web of Science ®Google Scholar
• Margit DH, Constantia EK, Andreas BS. In vitro evaluation of the viscoelastic properties of chitosan–thioglycolic acid conjugates. Eur J Pharm Biopharm. 2003;55:185–190.
   PubMed Web of Science ®Google Scholar
• Satheeshababu BK, Shivakumar KL. Synthesis of conjugated chitosan and its effect on drug permeation from transdermal patches. Indian J Pharm Sci. 2013;75(2):162–170.
   PubMed Web of Science ®Google Scholar
• Constantia EK, Wolfram F, Udo L, et al. Chitosan-thioglycolic acid conjugate: a new scaffold material for tissue engineering? Int J Pharm. 2003;256:183–189.
   PubMedGoogle Scholar
• Available from http://shodhganga.inflibnet.ac.in/bitstream/10603/48889/13/13_chapter_4.pdf.
   Google Scholar
• Rohith GB, Satheeshababu BK, Sadashivaiah R. Quantification of rasagiline mesylate by stability indicating RPHPLC method: development and validation. J Appl Pharm Sci. 2019;9:059–065.
   Google Scholar
• Mithilesh S, Mithun B, Jagdish R. Preformulation screening of repaglinide for transdermal antidiabetic therapy. J Drug Deliv Ther. 2017;7:103–109.
   Google Scholar
• Hemangi JP, Jitendra SP, Desai BG, et al. Permeability studies of anti hypertensive drug amlodipine besilate for transdermal delivery. Asian J Pharm Clin Res. 2010;3:31–34.
   Google Scholar
• Sahu RK, Jain A, Nayak S. Development and evaluation of transdermal patches of Colchicine. Der Pharmacia Lettre. 2012;4:330–343.
   Google Scholar
• Satheeshababu BK, Shruthinag R. Synthesis and charactersiation of chitosan conjugate; design and evaluation of membrane moderated type transdermal drug delivery system. Indian J Pharm Sci. 2015;77(4):405–412.
   PubMed Web of Science ®Google Scholar
• Available from https://tools.thermofisher.com/content/sfs/manuals/MAN0011216_Ellmans_Reag_UG.pdf.
   Google Scholar
• Wei Z, Ming K, Chao F, et al. Investigation of gelling behavior of thiolated chitosan in alkaline condition and its application in stent coating. Carbohydr Poly. 2016;136:307–315.
   PubMed Web of Science ®Google Scholar
• NIIR Board of Consultants and Engineers: The complete technology book on synthetic resins with formulae & processes. New Delhi: National Institute of Industrial Research; 2001.
   Google Scholar
• Wahid A, Sridhar BK, Shivakumar S. Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan. Indian J Pharm Sci. 2008;70(4):455–460.
   PubMed Web of Science ®Google Scholar
• Kalaria DR, Patel P, Patravale V, et al. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro. Int J Pharm. 2012;438(1-2):202–202-8.
   PubMedGoogle Scholar
• Ubaidulla U, Reddy MVS, Ruckmani K, et al. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS Pharm Sci Tech. 2007;8:2–9.
   PubMed Web of Science ®Google Scholar
• Pichayakorn W, Suksaeree J, Boonme P, et al. Nicotine transdermal patches using polymeric natural rubber as the matrix controlling system: effect of polymer and plasticizer blends. J Memb Sci. 2012;411–412:81–90.
   Web of Science ®Google Scholar
• Ammar HO, Ghorab M, El-Nahhas SA, et al. Polymeric matrix system for prolonged delivery of tramadol hydrochloride, part I: physicochemical evaluation. AAPS Pharm Sci Tech. 2009;10(1):7–20.
   PubMed Web of Science ®Google Scholar
• Verma PRP. Chandak Development of matrix controlled transdermal delivery systems of pentazocine: in-vitro/ in-vivo performance. Acta Pharm. 2009;59:171–186.
   PubMed Web of Science ®Google Scholar
• Sanjay B, Dinesh S, Neha S. Stability testing of pharmaceutical products. J Applied Pharm Sci. 2012;02:129–138.
   Google Scholar
• A standard protocol for deriving and assessment of stability part 3 – oral liquid medicines (solutions, emulsions, suspensions and syrups). NHS Pharmaceutical Quality Assurance Committee. https://www.sps.nhs.uk/articles/a-standard-protocol-for-deriving-and-assessment-of-stability-part-3-oral-liquid-medicines-solutions-emulsions-suspensions-and-syrups-edition-1-august-2014/
   Google Scholar
• Draize JH, Woodard G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–390.
   Web of Science ®Google Scholar
• Kalaria DR, Singhal M, Patravale V, et al. Simultaneous controlled iontophoretic delivery of pramipexole and rasagiline in vitro and in vivo: transdermal polypharmacy to treat Parkinson's disease. Eur J Pharm Biopharm. 2018;127:204–212.
   PubMed Web of Science ®Google Scholar
• Konda RK, Chandu BR, Challa BR, et al. Bio-analytical method development and validation of Rasagiline by high performance liquid chromatography tandem mass spectrometry detection and its application to pharmacokinetic study. J Pharm Anal. 2012;2(5):342–349.
   PubMedGoogle Scholar